Skip to content

Ginkgo Bioworks DNA Payments for finance leases

Payments for finance leases at other companies

Azenta logo
AzentaAZTA
$197K-18.6%
GeneDx Holdings logo
GeneDx HoldingsWGS
$495K-19.0%
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's payments for finance leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's payments for finance leases?
Ginkgo Bioworks (DNA) reported payments for finance leases of $19K in Q1 2026.
How has Ginkgo Bioworks's payments for finance leases changed year-over-year?
Ginkgo Bioworks's payments for finance leases decreased by 90.8% year-over-year, from $207K to $19K.
What is the long-term trend for Ginkgo Bioworks's payments for finance leases?
Over 4 years (2021 to 2025), Ginkgo Bioworks's payments for finance leases has grown at a -25.1% compound annual growth rate (CAGR), from $1.12M to $354K.
What does payments for finance leases mean?
Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.